View printer-friendly version << Back
American Anesthesiology Announces the Acquisition of Mt. Holly, NJ Practice

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Dec. 19, 2011-- American Anesthesiology, a division of MEDNAX, Inc., (NYSE: MD) today announced the acquisition of Burlington Anesthesia Associates (BAA), a physician group practice that provides anesthesia services in Mt. Holly, NJ.

Burlington Anesthesia Associates is the first New Jersey-based group practice to join American Anesthesiology. The practice consists of 17 anesthesiologists, who practice as part of an Anesthesia Care Team model that includes 25 Certified Registered Nurse Anesthetists (CRNAs). BAA provides anesthesia services at Virtua Memorial Hospital, in Mt. Holly, Virtua Memorial Ambulatory Surgery Center and various other out-patient clinics and surgery centers.

“There were several factors that went into our decision to become a part of American Anesthesiology,” said Richard Gargiulo, M.D., who will serve as medical director of the American Anesthesiology practice. “As we look forward into the changing face of healthcare, it was important for us to partner with a proven national group model that supports the growth of our longstanding practice and brings the resources necessary to provide stability as we focus on what we do best, take care of our patients. Our talented group of physicians can now focus on helping to shape the future of anesthesiology by focusing on better patient care through clinical quality improvement, research and education. Ultimately this will advance the care that we provide to our patients and local community.”

Today, American Anesthesiology has more than 850 anesthesia providers, including more than 400 physicians and 500 CRNAs and anesthesia assistants practicing in North and South Carolina, Virginia, Georgia, Florida, Texas, and New Jersey, with administrative offices in Sunrise, FL and Raleigh, NC.

MEDNAX paid cash for the practice, and the transaction is expected to be immediately accretive to its earnings. No additional terms of the transactions were disclosed.

With this acquisition, three physician group practices have become part of American Anesthesiology and seven physician group practices have become part of Pediatrix Medical Group during 2011.


MEDNAX, Inc., is a national medical group that comprises the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 300 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric critical care physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 900 anesthesia providers, including more than 375 physicians and 475 Certified Registered Nurse Anesthetists (CRNAs) and anesthesia assistants that provide comprehensive surgical anesthesia, acute and chronic pain, and critical care services in hospitals, surgery centers and physician offices. MEDNAX, through its affiliated professional corporations, employs more than 1,800 physicians in 34 states and Puerto Rico. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements which may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as "believe", "hope", "may", "anticipate", "should", "intend", "plan", "will", "expect", "estimate", "project", "positioned", "strategy" and similar expressions, and are based on assumptions and assessments made by MEDNAX's management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX's most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled "Risk Factors", as well MEDNAX's current reports on Form 8-K,filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

David Parker, 954-384-0175, x-5300
Vice President, Corporate Communications and Investor Relations